TABLE 4.
Sample size | Origin | Disease | miR‐32 change | References |
---|---|---|---|---|
88 | Serum | AMI | Up | REF:22 |
66 | Serum | CAC | Up | Liu et al. (2017)REF:6 |
68 | OS tissues | Osteosarcoma | Down | Lou et al. (2020)REF:52 |
58 | Retinoblastoma and adjacent non‐tumor tissues | Retinoblastoma | Down | Gao et al. (2020)REF:57 |
100 | Ovarian cancer tissues and adjacent normal tissues | Ovarian cancer | Down | Zhang et al. (2020)REF:60 |
34 | PBMCs | AML | Down | Wang et al. (2020a)REF:62 |
80 | Peripheral blood | ALL | Up | Mansouri et al. (2020)REF:65 |
29 | Myeloid tissues | Myeloma | Up | Sun et al. (2020b)REF:67 |
60 | ESCC tissues | ESCC | Up | Liu et al. (2019a)REF:17 |
54 | Colorectal cancer tissues | Colorectal cancer | Up | Liang et al. (2019)REF:69 |
28 | Colorectal cancer tissues and adjacent normal tissues | Colorectal cancer | Up | Chen et al. (2018)REF:72 |
80 | CCa tissues and adjacent normal tissues | Cervical cancer | Down | Liu et al. (2019b)REF:94 |
22 | PC tissues and the adjacent normal tissues | Pancreatic cancer | Up | Gao et al. (2017)REF:103 |
Abbreviations: ALL, acute lymphoblastic leukemia; AMI, acute myocardial infarction; AML, acute myeloid leukemia; CAC, coronary artery calcification; ESCC, esophageal squamous cell carcinoma; OS, osteosarcoma; PBMCs, peripheral blood mononuclear cells.